Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.26), $0.09 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.